Altmetrics
Downloads
151
Views
69
Comments
0
A peer-reviewed article of this preprint also exists.
This version is not peer-reviewed
Submitted:
18 June 2024
Posted:
19 June 2024
You are already at the latest version
Author, Year [Reference number] | Examinees/Patients | Analysed Factors - Methods | Results | Conclusions |
Kanerva L et al., 1993 [64] | 4 patients (an orthodontist, 2 dental technicians, and an in-house trained dental worker) | Patch testing for allergens in dental prostheses | All patients had positive allergic patch test reactions to MMA. | Dental personnel working with prostheses - higher risk of sensitization. Patients working with dental prostheses should be patch-tested with MMA, 2-HEMA, dimethacrylates, epoxy acrylates, and urethane acrylates to detect occupational ACD. |
Kiec-Swierczynska MK, 1996 [63] |
1619 patients suspected of occupational CD (examined during 1990-1994) | Patch testing to acrylates and methacrylates including EGDMA, MMA, 2-HEMA and TEGDMA | The most frequent sensitizers were: EGDMA (5 positive patch tests), MMA (4), 2-HEMA (4) and TEGDMA (4). Sensitivity to acrylates was diagnosed in 9 patients (4 dental technicians, 4 dentists, 1 textile printer). |
Dentists more sensitive to (meth)acrylate allergens and other allergens (metals and rubber additives). Dental techniques mainly sensitive to methacrylates. The textile printer was only sensitive to acrylates. |
Geukens S and Goossens A, 2001 [7] |
3,833 patients suspect of CD (during 1978-1999) | Patients were tested by patch test | The top three sensitizers were EGDMA (17 positive patch tests), 2-HEMA, (14), and TEGDMA (6). Almost the half of the examinees (14/31) were affected by (meth)acrylate-containing dental materials (including dentists and dental technology students). |
An increasing trend in dermatological issues associated with the expanding use of (meth)acrylates, particularly in dental professions. |
Wrangsjö K et al., 2001 [13] | 174 dental personnel referred as patients to the Department of Occupational and Environmental Dermatology, Stockholm (1995- 1998) | Patch testing to the Swedish standard series and a dental screening series. Testing for IgE-mediated allergy to natural rubber latex (NRL). |
Hand eczema affected 63% participants; 67% ICD, and 33% ACD. 59% of participants had positive reactions to standard series substances and 40% to the dental series. 22% had positive reactions to (meth)acrylates, primarily to multiple test preparations, including HEMA, EGDMA, and MMA. Allergy to NRL was recorded in 10% of patients. |
Irritant hand dermatitis was the predominant diagnosis among dental personnel. Contact allergy to (meth)acrylate in around 20% of the tested patients, mostly to 3 test substances; HEMA, EGDMA and MMA. (Meth)acrylate allergy often coexisted with atopy and/or other contact allergies. |
Goon AT et al., 2006 [14] |
1639 subjects were patch-tested at the Department of Occupational and Environmental Dermatology, Malmo, Sweden | Patch tests to to either dental patient series or dental personnel series including (meth)acrylate allergens: identification of common allergens and their prevalence in each group. | Positive patch tests to (meth)acrylate allergens were seen in 2.3% (30/1322) of the dental patients and 5.8% (18/310) of the dental personnel. The most common allergens for both groups were 2-HEMA, EGDMA, and MMA. |
2-HEMA is important screening allergen to detect contact allergy to (meth)acrylates used in the dental profession. |
Isaksson M et al., 2007 [4] | A case report (dental nurse with facial eczema allegedly caused by airborne methacrylates in the workplace) | Patch testing with serial dilutions of several methacrylates and work provocations in methacrylate environments | High reactivity to patch testing. Repeated exposure to methacrylates at work led to facial eczema; resolved when away. Efforts to collect the sensitizers using air pumps and filters failed. |
Facial dermatitis may be associated with airborne methacrylate exposure, which may involve allergy to ≥1 allergens. |
Ramos L et al., 2014 [5] |
An observational and retrospective study (January 2006–April 2013) | Evaluation and correlation of epidemiological and clinical parameters and positive patch test results with (meth)acrylates. | 37/122 patients show a positive patch test with an extended (meth)acrylate series. 25 cases (67.6%) were occupational. Hand eczema with pulpitis in 32 patients: 28 related to artificial nails, 3 to dental materials, and 2 to industrial work. Oral lesions associated with dental prostheses in 4 patients. 31/37 positive to >1 (meth)acrylate. Beauty technicians with artificial nails accounted for 80% of occupational cases. |
HEMA detected 80.6% of cases and it may serve as a reliable screening allergen. A broader range of allergens is advisable for accurate diagnosis. |
Muttardi K et al., 2016 [19] |
A retrospective study of 241 patients were patch tested with meth(acrylates) and cyanoacrylates (January 2012 – February 2015) | Patch testing with the mini-acrylate or extended acrylate series. | 16/241 patients had positive patch test reactions to (meth)acrylate or cyanoacrylate. Female predominance (M/F ratio of 1:15). |
(Meth)acrylate allergy is mainly occupational, but more common in younger women, especially beauticians and nail technicians. |
Havmose M et al., 2020 [2] | 1293 female patients patch-tested with HEMA | Two groups of patients based on their positive/negative patch test reactions to HEMA. MOAHLFA characteristics analyzed for both groups. |
31 (2.4%) of the tested examinees were positive to HEMA. | Sensitization and elicitation of ACD to HEMA primarily from artificial nail modeling systems; a significant health issue for consumers and certain professions. |
Gregoriou S et al., 2020 [6] | 156 female patients with ACD - using/performing cosmetic nail procedures (January 2009 – December 2018) | The incidence of positive sensitization to (meth)acrylates assessed using patch tests. | Contact allergy to ≥1 (meth)acrylates in 74.4%: 88.5% occupationally exposed, and 11.5% consumers. A statistically significant increase in (meth)acrylate ACD during 2014-2018 (79%) compared to 2009–2013 (55%). EGDMA was the most common sensitizer positive in 72.4%. Among acrylate-positive patients, the rate was 97.4%. |
A global trend of increasing (meth)acrylate sensitization among nail technicians and users of nail products with ACD. Enhancing preventive measures is essential. |
Opaliñska S et al., 2022 [3] | 8 women with CD related to acrylates found in hybrid varnishes | Manicure using a home acrylic nail kit and a non-professional UV lamp. Clinical and dermoscopic features were assessed. |
Allergen contact areas (skin and nails) were affected. Severity correlated with exposure duration. Common findings: subungual hyperkeratosis and onycholysis (8/8 patients), eczematous finger pulp fissuring (2/8 patients) (more specific). |
Nail changes from hybrid manicures may resemble onychomycosis or nail psoriasis (patch tests in uncertain cases) - ACD was suspected. Confirmed acrylate allergies require patient awareness and avoidance. |
de Groot AC, Rustemeyer T, 2024 [1] |
24 studies presenting case series and 168 case reports on patients with ACD attributed to HEMA | Review of cross- and co-sensitization, atypical contact allergy manifestations, HEMA versus other (meth)acrylates, HEMA's screening sensitivity, and its presence in commercial products. | Strong cross-allergy exists between HEMA, EGDMA, and HPMA. Reactions to EGDMA often from primary HEMA sensitization. Rare atypical manifestations of HEMA allergy include lichen planus, lymphomatoid papulosis, systemic CD, leukoderma post-positive patch tests, and systemic side effects (nausea, diarrhea, malaise, palpitations). |
HEMA is the most common patch test-positive methacrylate; an effective screening agent for other (meth)acrylates allergies. Sensitization to HEMA 2% pet. in patch tests is exceedingly rare. |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 MDPI (Basel, Switzerland) unless otherwise stated